Prognostic significance and predictors of the neutrophil-to-lymphocyte ratio in ovarian cancer
- 3 February 2014
- journal article
- research article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 132 (3), 542-550
- https://doi.org/10.1016/j.ygyno.2014.01.026
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Anti-MUC1 Antibodies and Ovarian Cancer Risk: Prospective Data from the Nurses' Health StudiesCancer Epidemiology, Biomarkers & Prevention, 2010
- Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytesMolecular Cancer, 2010
- Distinct Variants at LIN28B Influence Growth in Height from Birth to AdulthoodAmerican Journal of Human Genetics, 2010
- Unleashing the therapeutic potential of NOD-like receptorsNature Reviews Drug Discovery, 2009
- Genetic variation in LIN28B is associated with the timing of pubertyNature Genetics, 2009
- Cardiovascular Biomarkers in Groups of Established Smokers after a Decade of SmokingBasic & Clinical Pharmacology & Toxicology, 2009
- Neutrophil-to-lymphocyte ratio as an adjunct to CA-125 for the diagnosis of endometriosisFertility and Sterility, 2008
- Pre-treatment white blood cell subtypes as prognostic indicators in ovarian cancerEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2008
- Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatmentCancer Immunology, Immunotherapy, 2008
- Lifetime ovulatory cycles and ovarian cancer risk in 2 Italian case-control studiesAmerican Journal of Obstetrics and Gynecology, 2007